Nemaura to Present SugarBEAT® Clinical Performance Poster at ATTD, Berlin
December 12, 2018 08:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by...
Nemaura Successfully Completes Clinical Studies for SugarBEAT® FDA De-Novo 510(k) Submission
December 04, 2018 08:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
Nemaura Signs License and Distribution Agreement for SugarBEAT® Commercial Launch in Qatar
November 20, 2018 08:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by...
Nemaura Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
November 14, 2018 09:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by...
Nemaura Medical to Present at the Stifel 2018 Healthcare Conference
November 12, 2018 09:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by...
Nemaura Medical Inc. Reports Second Quarter 2018 Financial Results
November 08, 2018 09:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by...
Nemaura Successfully Develops Predictive Algorithms and Alarm Functionality for Continuous Glucose Monitor SugarBEAT®
November 07, 2018 09:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
Nemaura to Host Investor Webinar on October 23rd 2018 to Provide Update on Recent Developments
October 22, 2018 08:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England - Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
Nemaura Reports Positive Zero Finger-Stick Calibration Data for SugarBEAT® Continuous Glucose Monitor
September 25, 2018 08:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...
Nemaura Signs Letter of Intent for SugarBEAT® Commercial Launch in Qatar
September 18, 2018 08:00 ET
|
Nemaura Medical Inc
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by...